Cellular Immunology
Our Research
The most desired goal in bone marrow and organ transplantation as well as in autoimmune medicine is the development of drugs that will specifically and effectively target disease-related T lymphocyte clones with very few side effects. The treatment with the currently available chemical immunosuppressive drugs in the clinic is accompanied by severe side effects and is sometimes not effective in suppressing the disease. This is because, on the one hand, they attack biological processes that exist not only in the target cells but also in many other tissues in the body, and on the other they do not suppress all the T-cell-dependent immune mechanisms.